A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects
Clinical trial NCT07422142 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07422142
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.